569.SI Vicplas at S$0.09 on 09 Mar 2026: earnings due 12 Mar could shift outlook

The 569.SI stock, Vicplas International Ltd, trades at S$0.09 on the SES intraday tape as the company prepares to report results on 12 Mar 2026. Volume is light at 15,400 shares versus an average of 49,996, keeping intraday moves muted. Investors will watch margins, cash flow and order book detail in the report, since Vicplas has reported negative net income per share of -0.00 over the trailing twelve months. Our earnings spotlight connects today’s price action to fundamentals and the upcoming release.

569.SI stock: current price, liquidity and short-term trade signals

Vicplas (569.SI) is trading at S$0.09 with a 1-day change of 1.12% and intraday range S$0.09–S$0.09. Volume today is 15,400 versus an average 49,996, giving a relative volume of 0.31, which signals low liquidity for big orders. Technicals show an RSI of 41.00, Bollinger bands tight at S$0.09 middle, and an ADX of 21.34, suggesting a weak trend. Traders should expect price jumps around the earnings release on 12 Mar 2026 given thin trading depth.

569.SI stock earnings focus: what to watch on 12 Mar 2026

Key earnings items to monitor are revenue per share, margins and cash conversion. Trailing metrics show revenuePerShareTTM 0.24 and netIncomePerShareTTM -0.00, indicating narrow or negative profits. Vicplas reports no EPS consensus publicly and its last disclosed earnings timing is 12 Mar 2026. Management commentary on medical device orders and pipe projects across Singapore, Malaysia and China could move guidance. Watch working capital notes: days sales outstanding are 137.78 days and inventory days 124.17 days, which affect cash flow and margin sustainability.

569.SI stock fundamentals and valuation snapshot

Vicplas shows a market cap of S$45,996,903 and shares outstanding 511,076,699. Price-to-sales is 0.38 and price-to-book is 0.64, indicating the market values the company below book value. Return on equity is -3.22% and debt-to-equity is 0.58, reflecting modest leverage. Free cash flow per share is -0.01, and enterprise value to EBITDA is 11.76, which suggests valuation is not extreme versus profitability. These ratios show value attributes but flagged profitability and cash flow weakness.

569.SI stock sector context and peer comparisons

Vicplas sits in the Healthcare sector under Medical – Devices. The Singapore healthcare cohort has an average PE of 21.09 and average PB of 1.66. Compared with sector peers, Vicplas’ PB 0.64 is low, suggesting a deep-value profile but weaker margins. Sector 1-year performance is 26.74%, while Vicplas is up 7.14% over 12 months. Investors should weigh industry growth against company-level operational issues before assuming a valuation catch-up.

569.SI stock technical outlook and realistic price targets

Short-term technicals show limited momentum with stochastic %K at 19.05 and CCI at -75.46, consistent with an oversold bias. Given current liquidity, reasonable analyst-style scenarios are: a conservative price target S$0.06, base target S$0.09, and bull target S$0.12. The conservative target implies -33.33% downside versus today, while the bull target implies +33.33% upside. These targets reflect company fundamentals, thin trading and sector comparatives rather than formal broker estimates.

569.SI stock: Meyka AI grading and risk summary

Meyka AI rates 569.SI with a score of 61.57 out of 100 — Grade B (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score combines strengths like low price-to-book and reasonable interest coverage 10.33, with weaknesses in net income and free cash flow. Key risks are slow receivables collection, negative net margin -1.95%, and thin daily liquidity. Opportunities include recovery in medical device demand and pipe projects in regional markets. These grades are informational and not financial advice.

Final Thoughts

Vicplas International Ltd (569.SI) is trading at S$0.09 on the SES ahead of earnings on 12 Mar 2026. The company shows value-like metrics — PB 0.64 and PS 0.38 — but weak profitability and negative free cash flow remain concerns. Short-term risk is elevated because average volume is 49,996 and today’s trade is below that. Meyka AI’s forecast model projects a 12-month reference price of S$0.09, which implies a small downside-to-flat range versus today. Using a practical scenario approach, target ranges span S$0.06 (conservative) to S$0.12 (bull). For traders, the earnings report is the likely catalyst for intraday volatility. Long-term investors should demand clearer cash flow improvement and faster receivables turns before upgrading the thesis. Meyka AI provides this as model-based market analysis, and forecasts are projections, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.